Langer‐Gould, A., Smith, J. B., Li, B. H., Beaber, B. E., Brara, S. M., Debacker, J., . . . Ayeni, O. (2021). Multiple sclerosis, rituximab, and COVID‐19. Annals of Clinical & Translational Neurology, 8(4), 938-943. https://doi.org/10.1002/acn3.51342

Langer‐Gould, Annette, Jessica B. Smith, Bonnie H. Li, Brandon E. Beaber, Sonu M. Brara, Julie Debacker, Allen Scott Nielsen, Samira Amirova, and Oluwasheyi Ayeni. "Multiple Sclerosis, Rituximab, and COVID‐19." Annals of Clinical & Translational Neurology 8, no. 4 (2021): 938-943. https://doi.org/10.1002/acn3.51342.

Langer‐Gould, Annette, et al. "Multiple Sclerosis, Rituximab, and COVID‐19." Annals of Clinical & Translational Neurology, vol. 8, no. 4, 2021, pp. 938-943, https://doi.org/10.1002/acn3.51342.